Susan Dent MD FRCPC
@susandent.bsky.social
Medical Oncologist /Cardio-Oncologist
Wilmot Cancer Institute
Professor of Medicine, University of Rochester
Director of the Judy DiMarzo Survivorship program
Director of Cardio-Oncology
Rochester, New York
President International Cardio-Oncology Society
Wilmot Cancer Institute
Professor of Medicine, University of Rochester
Director of the Judy DiMarzo Survivorship program
Director of Cardio-Oncology
Rochester, New York
President International Cardio-Oncology Society
Best of luck in your new adventures. You have made such significant contribution’s to cancer care and I know you will continue to do so……
May 13, 2025 at 2:54 PM
Best of luck in your new adventures. You have made such significant contribution’s to cancer care and I know you will continue to do so……
I missed this poll but this is a bit scary!!! 8 % said Ribociclib which is absolutely contraindicated and honestly I would be hesitant to start her on any cdk4/6 inhibitor with a QTc that high particularly given she is on seroquel. Speed dial to cardio-oncology! Education needed!
January 31, 2025 at 1:31 AM
I missed this poll but this is a bit scary!!! 8 % said Ribociclib which is absolutely contraindicated and honestly I would be hesitant to start her on any cdk4/6 inhibitor with a QTc that high particularly given she is on seroquel. Speed dial to cardio-oncology! Education needed!
Cure Cancer Save Hearts!
December 23, 2024 at 10:39 PM
Cure Cancer Save Hearts!
Sorry Save Hearts
December 23, 2024 at 10:21 PM
Sorry Save Hearts
Reposted by Susan Dent MD FRCPC
3. Insurance profits outpace health care spending
December 20, 2024 at 4:37 PM
3. Insurance profits outpace health care spending